Chengzhi Shareholding Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 6.12%

Chengzhi Shareholding Co Ltd (000990) has an Asset Resilience Ratio of 6.12% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.72 Billion

≈ $252.11 Million USD Cash + Short-term Investments

Total Assets

CN¥28.15 Billion

≈ $4.12 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Chengzhi Shareholding Co Ltd's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Chengzhi Shareholding Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Chengzhi Shareholding Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 000990 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.72 Billion	6.12%
Total Liquid Assets	CN¥1.72 Billion	6.12%

Asset Resilience Insights

Limited Liquidity: Chengzhi Shareholding Co Ltd maintains only 6.12% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Chengzhi Shareholding Co Ltd Industry Peers by Asset Resilience Ratio

Compare Chengzhi Shareholding Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Genfit S.A. PA:GNFT	Biotechnology	64.01%
Hyundai Bioscience Co. Ltd KQ:048410	Biotechnology	22.98%
Altimmune Inc NASDAQ:ALT	Biotechnology	82.06%
Clarity Pharmaceuticals Ltd AU:CU6	Biotechnology	73.99%
Jiangsu GDK Biotechnology Co Ltd SHG:688670	Biotechnology	9.82%

Annual Asset Resilience Ratio for Chengzhi Shareholding Co Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Chengzhi Shareholding Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	6.24%	CN¥1.73 Billion ≈ $253.84 Million	CN¥27.79 Billion ≈ $4.07 Billion	+1.17pp
2024-12-31	5.07%	CN¥1.37 Billion ≈ $200.79 Million	CN¥27.08 Billion ≈ $3.96 Billion	-0.37pp
2023-12-31	5.44%	CN¥1.40 Billion ≈ $204.87 Million	CN¥25.74 Billion ≈ $3.77 Billion	+3.29pp
2022-12-31	2.15%	CN¥526.50 Million ≈ $77.04 Million	CN¥24.53 Billion ≈ $3.59 Billion	+12.83pp
2021-12-31	-10.69%	CN¥-2.61 Billion ≈ $-382.32 Million	CN¥24.45 Billion ≈ $3.58 Billion	-10.69pp
2020-12-31	0.00%	CN¥275.00K ≈ $40.24K	CN¥24.41 Billion ≈ $3.57 Billion	+8.25pp
2019-12-31	-8.25%	CN¥-1.98 Billion ≈ $-290.41 Million	CN¥24.06 Billion ≈ $3.52 Billion	-15.79pp
2018-12-31	7.54%	CN¥1.76 Billion ≈ $257.99 Million	CN¥23.38 Billion ≈ $3.42 Billion	-1.50pp
2017-12-31	9.04%	CN¥1.90 Billion ≈ $278.03 Million	CN¥21.02 Billion ≈ $3.08 Billion	+7.86pp
2016-12-31	1.18%	CN¥237.00 Million ≈ $34.68 Million	CN¥20.15 Billion ≈ $2.95 Billion	--

pp = percentage points

About Chengzhi Shareholding Co Ltd

SHE:000990 China Biotechnology

Market Cap

$1.64 Billion

CN¥11.20 Billion CNY

Market Cap Rank

#6774 Global

#1361 in China

Share Price

CN¥9.22

Change (1 day)

-0.32%

52-Week Range

CN¥7.24 - CN¥13.17

All Time High

CN¥30.90